{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:41:06Z","timestamp":1785177666972,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":587,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Takotsubo syndrome (TS) is a heart condition mimicking acute myocardial infarction. TS is characterized by a sudden weakening of the heart muscle, usually triggered by physical or emotional stress. In this study, we aimed to investigate the effect of pharmacological interventions on short- and long-term mortality in patients with TS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We analysed data from the SWEDEHEART (the Swedish Web System for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies) registry, which included patients who underwent coronary angiography between 2009 and 2016. In total, we identified 1724 patients with TS among 228 263 individuals in the registry. The average age was 66 \u00b1 14 years, and 77% were female. Nearly half of the TS patients (49.4%) presented with non-ST-elevation acute coronary syndrome, and a quarter (25.9%) presented with ST-elevation myocardial infarction. Most patients (79.1%) had non-obstructive coronary artery disease on angiography, while 11.7% had a single-vessel disease and 9.2% had a multivessel disease. All patients received at least one pharmacological intervention; most of them used beta-blockers (77.8% orally and 8.3% intravenously) or antiplatelet agents [aspirin (66.7%) and P2Y12 inhibitors (43.6%)]. According to the Kaplan\u2013Meier estimator, the probability of all-cause mortality was 2.5% after 30 days and 16.6% after 6 years. The median follow-up time was 877 days. Intravenous use of inotropes and diuretics was associated with increased 30 day mortality in TS [hazard ratio (HR) = 9.92 (P &amp;lt; 0.001) and HR = 3.22 (P = 0.001), respectively], while angiotensin-converting enzyme inhibitors and statins were associated with decreased long-term mortality [HR = 0.60 (P = 0.025) and HR = 0.62 (P = 0.040), respectively]. Unfractionated and low-molecular-weight heparins were associated with reduced 30 day mortality [HR = 0.63 (P = 0.01)]. Angiotensin receptor blockers, oral anticoagulants, P2Y12 antagonists, aspirin, and beta-blockers did not statistically correlate with mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that some medications commonly used to treat TS are associated with higher mortality, while others have lower mortality. These results could inform clinical decision-making and improve patient outcomes in TS. Further research is warranted to validate these findings and to identify optimal pharmacological interventions for patients with TS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14713","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T01:34:02Z","timestamp":1709861642000},"page":"1720-1729","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of Pharmacological Interventions on Mortality in Patients with Takotsubo Syndrome: A Report from the SWEDEHEART Registry"],"prefix":"10.1093","volume":"11","author":[{"given":"Petur","family":"Petursson","sequence":"first","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"O\u0161tarija\u0161","sequence":"additional","affiliation":[{"name":"University of P\u00e9cs Medical School , P\u00e9cs ,","place":["Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Redfors","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truls","family":"R\u00e5munddal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Anger\u00e5s","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"V\u00f6lz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araz","family":"Rawshani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Hambraeus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Falun Hospital , Falun ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Koul","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Alfredsson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Link\u00f6ping University Hospital , Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ume\u00e5 University Hospital , Ume\u00e5 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henareh","family":"Loghman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology, S\u00f6dra Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Fr\u00f6bert","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u00d6rebro University Hospital , \u00d6rebro ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Jernberg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Danderyd University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"James","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Uppsala University Hospital , Uppsala ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erlinge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3875-8621","authenticated-orcid":false,"given":"Elmir","family":"Omerovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"2026012113025243400_ehf214713-bib-0001","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ejhf.424","article-title":"Current state of knowledge on Takotsubo syndrome: A position statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology","volume":"18","author":"Lyon","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012113025243400_ehf214713-bib-0002","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jacc.2020.10.060","article-title":"Pathophysiology of Takotsubo syndrome: JACC state-of-the-art review","volume":"77","author":"Lyon","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026012113025243400_ehf214713-bib-0003","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","article-title":"International expert consensus document on Takotsubo syndrome (part I): Clinical characteristics, diagnostic criteria, and pathophysiology","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012113025243400_ehf214713-bib-0004","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jmv.29003","article-title":"Myocardial stunning due to simultaneous multivessel coronary spasms: A review of 5 cases","volume":"21","author":"Dote","year":"1991","journal-title":"J Cardiol"},{"key":"2026012113025243400_ehf214713-bib-0005","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.ijcard.2011.12.025","article-title":"Stress-induced cardiomyopathy in a patient with chronic spinal cord transection at the level of C5: Endocrinologically mediated catecholamine toxicity","volume":"159","author":"Redfors","year":"2012","journal-title":"Int J Cardiol"},{"key":"2026012113025243400_ehf214713-bib-0006","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1016\/j.ijcard.2013.06.128","article-title":"Stress-induced cardiomyopathy in the critically ill\u2014Why inotropes fail to improve outcome","volume":"168","author":"Redfors","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026012113025243400_ehf214713-bib-0007","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.hfc.2016.06.008","article-title":"Takotsubo syndrome\u2014Scientific basis for current treatment strategies","volume":"12","author":"Omerovic","year":"2016","journal-title":"Heart Fail Clin"},{"key":"2026012113025243400_ehf214713-bib-0008","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/heartjnl-2016-309783","article-title":"Takotsubo syndrome: Aetiology, presentation and treatment","volume":"103","author":"Kato","year":"2017","journal-title":"Heart"},{"key":"2026012113025243400_ehf214713-bib-0009","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/jcm12010125","article-title":"Broken heart syndrome: Evolving molecular mechanisms and principles of management","volume":"12","author":"Sethi","year":"2022","journal-title":"J Clin Med"},{"key":"2026012113025243400_ehf214713-bib-0010","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/14017431.2011.565794","article-title":"How to think about stress-induced cardiomyopathy?\u2014Think out of the box!","volume":"45","author":"Omerovic","year":"2011","journal-title":"Scand Cardiovasc J"},{"key":"2026012113025243400_ehf214713-bib-0011","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A test of missing completely at random for multivariate data with missing values","volume":"83","author":"Little","year":"1988","journal-title":"J Am Stat Assoc"},{"key":"2026012113025243400_ehf214713-bib-0012","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2014Non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"2026012113025243400_ehf214713-bib-0013","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","article-title":"Inference and missing data","volume":"63","author":"Rubin","year":"1976","journal-title":"Biometrika"},{"key":"2026012113025243400_ehf214713-bib-0014","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","author":"Anderson","year":"1983","journal-title":"J Clin Oncol"},{"key":"2026012113025243400_ehf214713-bib-0015","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"2026012113025243400_ehf214713-bib-0016","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"2026012113025243400_ehf214713-bib-0017","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026012113025243400_ehf214713-bib-0018","doi-asserted-by":"publisher","DOI":"10.21105\/joss.04495","article-title":"tipr: An R package for sensitivity analyses for unmeasured confounders","volume":"7","author":"McGowan","year":"2022","journal-title":"J Open Sourc Soft"},{"key":"2026012113025243400_ehf214713-bib-0019","volume-title":"Regression Modeling Strategies With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Frank","year":"2015"},{"key":"2026012113025243400_ehf214713-bib-0020","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.cardfail.2022.02.002","article-title":"Long-term risk of death and hospitalization in patients with heart failure and Takotsubo syndrome: Insights from a nationwide cohort","volume":"28","author":"Butt","year":"2022","journal-title":"J Card Fail"},{"key":"2026012113025243400_ehf214713-bib-0021","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000918","article-title":"Postdischarge outcome after Takotsubo syndrome compared with patients post-ACS and those without prior CVD: ANZACS-QI 19","volume":"5","author":"Looi","year":"2018","journal-title":"Open Heart"},{"key":"2026012113025243400_ehf214713-bib-0022","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.017290","article-title":"Short- and long-term clinical outcomes for patients with Takotsubo syndrome and patients with myocardial infarction: A report from the Swedish Coronary Angiography and Angioplasty Registry","volume":"10","author":"Redfors","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026012113025243400_ehf214713-bib-0023","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1111\/1755-5922.12047","article-title":"Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: A case series","volume":"31","author":"Santoro","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"2026012113025243400_ehf214713-bib-0024","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00059-013-3896-x","article-title":"Recurrent takotsubo cardiomyopathy: Variable pattern of ventricular involvement","volume":"39","author":"Singh","year":"2014","journal-title":"Herz"},{"key":"2026012113025243400_ehf214713-bib-0025","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of takotsubo (stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012113025243400_ehf214713-bib-0026","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/heartjnl-2021-320543","article-title":"Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome","volume":"108","author":"Silverio","year":"2022","journal-title":"Heart"},{"key":"2026012113025243400_ehf214713-bib-0027","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab724.1175","article-title":"Dobutamine stress echocardiography-induced Takotsubo cardiomyopathy. Which triggers?","volume":"42","author":"Meimoun","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113025243400_ehf214713-bib-0028","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.ijcard.2012.12.092","article-title":"Novel rat model reveals important roles of \u03b2-adrenoreceptors in stress-induced cardiomyopathy","volume":"168","author":"Shao","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026012113025243400_ehf214713-bib-0029","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1002\/ehf2.13486","article-title":"Levosimendan improves the acute course of takotsubo syndrome: A pooled analysis","volume":"8","author":"Jaguszewski","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012113025243400_ehf214713-bib-0030","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-14-147","article-title":"Prevalence, associated factors and management implications of left ventricular outflow tract obstruction in takotsubo cardiomyopathy: A two-year, two-center experience","volume":"14","author":"De Backer","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012113025243400_ehf214713-bib-0031","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"2026012113025243400_ehf214713-bib-0032","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijcard.2018.12.045","article-title":"Effects of pretreatment with cardiostimulants and beta-blockers on isoprenaline-induced takotsubo-like cardiac dysfunction in rats","volume":"281","author":"Ali","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026012113025243400_ehf214713-bib-0033","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","article-title":"Loop diuretics in acute decompensated heart failure: Necessary? Evil? A necessary evil?","volume":"2","author":"Felker","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2026012113025243400_ehf214713-bib-0034","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10286-012-0162-x","article-title":"Sympathetic nerve activity in stress-induced cardiomyopathy","volume":"22","author":"Sverrisdottir","year":"2012","journal-title":"Clin Auton Res"},{"key":"2026012113025243400_ehf214713-bib-0035","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/eurheartj\/13.suppl_g.28","article-title":"Neurohormonal consequences of diuretics in different cardiovascular syndromes","volume":"13","author":"Burnier","year":"1992","journal-title":"Eur Heart J"},{"key":"2026012113025243400_ehf214713-bib-0036","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s10741-021-10099-5","article-title":"Prognostic impact of antiplatelet therapy in Takotsubo syndrome: A systematic review and meta-analysis of the literature","volume":"27","author":"Rizzetto","year":"2022","journal-title":"Heart Fail Rev"},{"key":"2026012113025243400_ehf214713-bib-0037","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.amjcard.2013.01.304","article-title":"Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathy","volume":"111","author":"Cecchi","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026012113025243400_ehf214713-bib-0038","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/clc.23137","article-title":"Thrombo-embolic complications in takotsubo syndrome: Review and demonstration of an illustrative case","volume":"42","author":"Y-Hassan","year":"2019","journal-title":"Clin Cardiol"},{"key":"2026012113025243400_ehf214713-bib-0039","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12872-017-0686-z","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: A meta-analysis of randomized controlled trials","volume":"17","author":"Tai","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012113025243400_ehf214713-bib-0040","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ahj.2022.11.010","article-title":"Rationale and design of BROKEN-SWEDEHEART: A registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome","volume":"257","author":"Omerovic","year":"2023","journal-title":"Am Heart J"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/3\/1720\/64070563\/eschf_11_3_1720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/3\/1720\/64070563\/eschf_11_3_1720.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:03:05Z","timestamp":1769018585000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/3\/1720\/8234033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,7]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14713","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"2023-09-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}